Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.

1. STOCK NEWS:

Altria (MO) agreed to acquire NJOY Holdings for $2.75B in cash [read more]
Ciena (CIEN) reported better-than-expected Q1 results [read more]
Silvergate Capital (SI) announced that it has discontinued the Silvergate Exchange Network [read more]
Silver Lake offers $18.15 per share in cash for Qualtrics (XM) [read more]
Amazon's (AMZN) "Creed III" won the weekend domestic box office with a better-than-expected $58.7M [read more]

2. WALL STREET CALLS:

Apple (AAPL) initiated with a Buy at Goldman Sachs [read more]
Monster Beverage (MNST) upgraded to Buy from Neutral at Redburn [read more]
Vir Biotechnology (VIR) upgraded to Overweight from Neutral at JPMorgan [read more]
Silvergate Capital (SI) downgraded to Underperform at Wedbush and to Sell at Compass Point [read more]
RH (RH) cut to Hold at Jefferies with luxury housing market "struggling to stabilize" [read more]

3. AROUND THE WEB:

Proxy advisers are urging shareholders to reject Ritchie Bros' (RBA) bid for IAA (IAA), Reuters reports [read more]
Sirius XM (SIRI) is laying off 8% of its workforce, The Hollywood Reporter says [read more]
Kerrisdale is short on C3.ai (AI) on "poor customer traction" [read more]
UBS (UBS) CEO Ralph Hamers will get a 11% pay hike while cutting bonuses, Bloomberg reports [read more]
Caterpillar (CAT) won't close union plants under a new contract, WSJ reports [read more]

4. MOVERS:

BridgeBio (BBIO) gain after announcing Phase 2 cohort 5 results of infigratinib [read more]
Vistra (VST) advances after announcing it will acquire Energy Harbor (ENGH) for $3B in cash [read more]
AST SpaceMobile (ASTS) higher after entering a teaming agreement with Fairwinds Technologies [read more]
Aclaris Therapeutics (ACRS) lower after announcing preliminary data from Phase 2 study of ATI-450 [read more]
Esperion (ESPR) lower after announcing full results from its CLEAR outcomes study [read more]

5. EARNINGS/GUIDANCE:

BlackLine (BL) reaffirmed its Q1 and FY23 guidance [read more]
Valaris (VAL) provided an adjusted EBITDA outlook for Q1 and FY23 [read more]
Lordstown Motors (RIDE) reported a year-over-year decline in Q4 earnings [read more]
Verrica Pharmaceuticals (VRCA) reported mixed Q4 results [read more]
CECO Environmental (CECO) provided a "beat and raise" report for Q4 [read more]

INDEXES:

Near midday, the Dow was up 125.11, or 0.37%, to 33,516.08, the Nasdaq was up 115.21, or 0.99%, to 11,804.21, and the S&P 500 was up 26.50, or 0.66%, to 4,072.14.